Extended local anesthesia enabled by flavonoid permeation enhancers

Y Yiyuan Han (Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Boston Children’s Hospital, Harvard Medical School) M Matthew Torre (Department of Pathology and Immunology, Baylor College of Medicine) X Xiaojing Ma (Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Boston Children’s Hospital, Harvard Medical School) T Tianrui Xue (Department of Chemistry) Y Yuan Wang S Sooyeon Jo (Department of Neurobiology, Harvard Medical School) A Akie Fujita (Department of Neurobiology, Harvard Medical School) B Bruce P. Bean (Department of Neurobiology, Harvard Medical School) D Daniel S. Kohane (Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Boston Children’s Hospital, Harvard Medical School)

Abstract

Site 1 sodium channel blockers (S1SCBs), such as tetrodotoxin (TTX) and neosaxitoxin, are ultrapotent local anesthetics with low tissue toxicity. Their duration of action is relatively brief, but increasing the dose can lead to systemic toxicity. Here, we report that selected flavonoids—puerarin (PUE), naringenin, and kaempferol—prolong nerve block from S1SCBs 4- to 25-fold. Using both tympanic membrane (TM) permeation and sciatic nerve fluorescence distribution models, we demonstrate the flavonoids increase drug penetration across biological barriers (the TM and the barriers in and around nerve), suggesting that they act as chemical permeation enhancers (CPEs). Importantly, flavonoids exhibited minimal tissue toxicity compared to conventional CPEs. Coencapsulation of TTX and PUE into a liposomal delivery system further prolonged local anesthesia to over 25 d from a single injection. These findings establish flavonoid compounds as a safe class of CPEs and provide a platform of long-acting, nonopioid pain therapies. Flavonoids may be attractive alternatives to conventional CPEs in biomedical applications.

Article Details

Volume / Issue Vol. 123, Issue 10
Published March 10, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (9)

Y

Yiyuan Han

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Boston Children’s Hospital, Harvard Medical School

M

Matthew Torre

Department of Pathology and Immunology, Baylor College of Medicine

X

Xiaojing Ma

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Boston Children’s Hospital, Harvard Medical School

T

Tianrui Xue

Department of Chemistry

Y

Yuan Wang

S

Sooyeon Jo

Department of Neurobiology, Harvard Medical School

A

Akie Fujita

Department of Neurobiology, Harvard Medical School

B

Bruce P. Bean

Department of Neurobiology, Harvard Medical School

D

Daniel S. Kohane

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Boston Children’s Hospital, Harvard Medical School